Xenon Pharmaceuticals Inc

1. 01

   Behind SPY and its sector fund XLV over 1 year

   1 month: +7.2% (SPY −1.6%, XLV +13.5%). 3 months: −39.1% (SPY −0.4%, XLV +15.5%). 1 year: +0.3% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: XENE, SPY and XLV · as of 4 Nov 2026

2. 02

   Below its 50- and 200-day averages

   The 4 Nov 2026 close of $39.19 was 11.0% below its 50-day average ($44.01) and 25.1% below its 200-day average ($52.33). It has closed below the 200-day for 34 sessions, since 18 Sep 2026. The 50-day average crossed below the 200-day on 13 Oct 2026, 16 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

3. 03

   17.4% above its 52-week low

   Closed at $39.19 on 4 Nov 2026: 46.1% below the 52-week high of $72.66 (9 Jul 2026) and 17.4% above the low of $33.38 (16 Oct 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

4. 04

   Short interest at 7.6% of shares outstanding

   7.3M shares were sold short at the 15 Oct 2026 settlement, 7.6% of the 96.7M shares outstanding; covering them would take 4.0 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 4 Nov 2026 close